Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission
International Journal of Molecular Sciences · 2024
DOI: 10.3390/ijms252111351 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Sunmee Park und 3 weiteren Autor:innen. Beteiligte Einrichtung: Center for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA 94025, USA. Hauptthemen laut MEDLINE: Wakefulness, Receptors, G-Protein-Coupled, Dopamine, Mice, Inbred C57BL. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NINDS NIH HHS, NIH HHS, NIH.
Abstract (Originalsprache)
Trace amine-associated receptor 1 (TAAR1) is a negative regulator of dopamine (DA) release. The partial TAAR1 agonist RO5263397 promotes wakefulness and suppresses NREM and REM sleep in rodents and non-human primates. We tested the hypothesis that the TAAR1-mediated effects on sleep/wake regulation were due, in part, to DA release. Male C57BL6/J mice (n = 8) were intraperitoneally administered the D1R antagonist SCH23390, the D2R antagonist eticlopride, a combination of D1R + D2R antagonists, or saline at ZT5.5, followed 30 min later by RO5263397 or vehicle per os. EEG, EMG, subcutaneous temperature, and activity were recorded across the 8 treatments and sleep architecture was analyzed for 6 h post-dosing. As described previously, RO5263397 increased wakefulness and delayed NREM and REM sleep onset. D1, D2, and D1 + D2 pretreatment reduced RO5263397-induced wakefulness for 1–2 h after dosing but only the D1 antagonist significantly reduced the TAAR1-mediated increase in NREM latency. Neither the D1 nor the D2 antagonist affected the TAAR1-mediated suppression of REM sleep. These results suggest that, whereas the TAAR1 effects on wakefulness are mediated, in part, through the D2R, D1R activation plays a role in reversing the TAAR1-mediated increase in NREM sleep latency. In contrast, the TAAR1-mediated suppression of REM sleep appears not to involve D1R or D2R mechanisms.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Center for Neuroscience, Biosciences Division, SRI International, Menlo Park, CA 94025, USA.
- Neuroscience and Rare Diseases Discovery & Translational Area, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd., CH-4070 Basel, Switzerland.
ORCID-Profile: Sunmee Park, Marius C Hoener, Thomas S Kilduff
Förderung
- NINDS NIH HHS
- NIH HHS
- NIH
Zitieren
APA
Park, S., Heu, J., Hoener, M. C., & Kilduff, T. S. (2024). Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms252111351
Vancouver
Park S, Heu J, Hoener MC, Kilduff TS. Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms252111351
BibTeX
@article{Park2024,
author = {Park, Sunmee and Heu, Jasmine and Hoener, Marius C and Kilduff, Thomas S},
title = {Wakefulness Induced by TAAR1 Partial Agonism in Mice Is Mediated Through Dopaminergic Neurotransmission},
journal = {International Journal of Molecular Sciences},
year = {2024},
doi = {10.3390/ijms252111351}
}
EUVIMED